Content
Federal Reserve Predicts No Rate Increase Until End Of 2023
Article By:
Adam Vettese
Read
Thursday, September 17, 2020 5:58 AM EDT
On Wednesday the Fed said it won’t be raising interest rates from their near-zero level for years. After a two-day policy meeting, the bank released new projections in which 13 of 17 officials said they expect to keep rates near zero until 2023.
Unity Software Diversifies Its IPO Options
Article By:
Lipper Alpha Insight
Read
Wednesday, September 16, 2020 5:14 AM EDT
The options for companies going public are diversifying. The latest wrinkle comes from Unity Software.
In this article: U
Apple Stock Falls Flat After Raft Of Product Announcements
Article By:
Adam Vettese
Read
Wednesday, September 16, 2020 4:11 AM EDT
Apple which is worth more than $2trn despite its recent retreat from record highs, revealed a new iPad Air, generation 6 Apple Watch and pricing for new subscriptions bundles that wrap together services such as Apple TV, iCloud and Apple Music.
IPO Outlook For The Week: Snowflake And Amwell Lead Busy 12 IPO Lineup
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
Is The Bumble IPO Worth Investing In?
Article By:
Money Morning
Read
Saturday, September 5, 2020 1:03 PM EDT
With the current pandemic, it would not be surprising to see dating become further and further digitized. For companies like Bumble, this is fertile ground, which is probably why we're hearing about the Bumble IPO. But is the IPO worth investing in?
Snowflake IPO: Opportunity, Risk, And The Big Unknown
Article By:
Andres Cardenal
Read
Monday, August 31, 2020 10:21 AM EDT
Snowflake has a great business model and abundant potential for growth. Top line growth and retention metrics are outstanding. The company's relationship with the big cloud players and aggressive investments for growth are key risk factors.
In this article: SNOW
Week In Review: Antengene Approved By Hong Kong Exchange For $200 Million IPO
Article By:
ChinaBio® Today
Read
Saturday, August 29, 2020 12:43 PM EDT
Antengene, a three-year old Shanghai startup originally backed by Celgene, will conduct a Hong Kong IPO that is expected to raise $200 million. BeiGene acquired China rights to Bio-Thera's Avastin® biosimilar in an agreement worth up to $165 million.
Let The Wookie Win
Article By:
Tim Knight
Read
Saturday, August 29, 2020 6:00 AM EDT
Back in the early dotcom days, Pets.com became a notorious flop. Today seems to be a different story, as Chewy.com passes its first IPO anniversary.
In this article: CHWY
GoodRx Files Registration Statement For Proposed Initial Public Offering
Article By:
Business Wire
Read
Saturday, August 29, 2020 1:33 AM EDT
GoodRx, a leading consumer-focused digital healthcare platform and the most downloaded medical app for the last three years, intends to list Class A common stock on the Nasdaq Global Select Market as GDRX.
Is Snowflake Stock A Buy After The IPO?
Article By:
Money Morning
Read
Friday, August 28, 2020 3:32 PM EDT
If you haven't checked out the cloud computing market, do it. In 2019, researchers predicted this industry would grow from $266 million to $832 million, a total of 212%, by 2025. And the latest tech IPOs are contenders to grab a piece of that 212%.
Blue Chip Jackpots: A Tale Of Two Puzzles
Article By:
Samar Abuwarda, MSc
Read
Sunday, August 23, 2020 6:26 PM EDT
Both jackpot stories pose puzzles. Is $3T valuation attainable for Apple in 2020, the pandemic year? Why did Jack Ma choose Chinese cities to IPO in this time instead of NY?